Appili Therapeutics 대차 대조표 상태
재무 상태 기준 확인 0/6
Appili Therapeutics has a total shareholder equity of CA$-12.4M and total debt of CA$10.1M, which brings its debt-to-equity ratio to -81.2%. Its total assets and total liabilities are CA$2.2M and CA$14.6M respectively.
주요 정보
-81.2%
부채 비율
CA$10.05m
부채
| 이자 보상 비율 | n/a |
| 현금 | CA$301.27k |
| 주식 | -CA$12.39m |
| 총 부채 | CA$14.62m |
| 총 자산 | CA$2.23m |
재무 상태 분석
단기부채: APLI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
장기 부채: APLI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: APLI has negative shareholder equity, which is a more serious situation than a high debt level.
부채 감소: APLI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: APLI has less than a year of cash runway based on its current free cash flow.
예측 현금 활주로: APLI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.1% each year